{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:08:03Z","timestamp":1785802083262,"version":"3.56.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.kint.2018.01.021","type":"journal-article","created":{"date-parts":[[2018,5,20]],"date-time":"2018-05-20T20:12:22Z","timestamp":1526847142000},"page":"1452-1464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Ex\u00a0vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy"],"prefix":"10.1016","volume":"93","author":[{"given":"Sybille","family":"Landwehr-Kenzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Zobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Landwehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schmueck-Henneresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schachtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Roemhild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Reinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.01.021_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1600-6143.2010.03409.x","article-title":"Renal allograft survival: getting better all the time","volume":"11","author":"Segev","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ndt\/gfq730","article-title":"Kidney allograft survival: the long and short of it","volume":"26","author":"Lodhi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib4","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0041-1345(01)01959-5","article-title":"Overview of side effects of immunosuppressive therapy","volume":"33","author":"Paul","year":"2001","journal-title":"Transpl Proc"},{"key":"10.1016\/j.kint.2018.01.021_bib5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nrneph.2010.102","article-title":"Malignancy after renal transplantation: the role of immunosuppression","volume":"6","author":"Rama","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2018.01.021_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/MOT.0b013e32833e1673","article-title":"Malignancies in pediatric solid organ transplant recipients: epidemiology, risk factors, and prophylactic approaches","volume":"15","author":"Paramesh","year":"2010","journal-title":"Curr Opin Organ Transpl"},{"key":"10.1016\/j.kint.2018.01.021_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2018.01.021_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","article-title":"Imbalance of regulatory T cells in human autoimmune diseases","volume":"117","author":"Dejaco","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.kint.2018.01.021_bib9","doi-asserted-by":"crossref","first-page":"e1001043","DOI":"10.1371\/journal.ppat.1001043","article-title":"Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection","volume":"6","author":"Johanns","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.kint.2018.01.021_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.0105-2896.2006.00412.x","article-title":"Regulatory T cells in virus infections","volume":"212","author":"Rouse","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2018.01.021_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MOT.0b013e32833bfadc","article-title":"Adoptive regulatory T cell therapy: challenges in clinical transplantation","volume":"15","author":"Safinia","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/TP.0b013e3181ebf782","article-title":"Non-human primate regulatory T cells: current biology and implications for transplantation","volume":"90","author":"Dons","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.01.021_bib13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2006-02-002774","article-title":"Regulatory T cells in cancer","volume":"108","author":"Beyer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.01.021_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08916931003782114","article-title":"Regulatory immune cell subsets in autoimmunity","volume":"44","author":"La Cava","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.kint.2018.01.021_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.immuni.2007.08.001","article-title":"The expanding universe of regulatory T cell subsets in cancer","volume":"27","author":"Gajewski","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.01.021_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2018.01.021_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1600-065X.2001.1820117.x","article-title":"Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells","volume":"182","author":"Weiner","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2018.01.021_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-065X.2001.1820105.x","article-title":"Type 1 T regulatory cells","volume":"182","author":"Roncarolo","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2018.01.021_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-59745-395-0_6","article-title":"Isolation, expansion and characterization of human natural and adaptive regulatory T cells","volume":"380","author":"Gregori","year":"2007","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.kint.2018.01.021_bib20","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/eji.201040909","article-title":"Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome","volume":"41","author":"Passerini","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2567.2012.03570.x","article-title":"Circulating lymphocyte subsets in different clinical situations after renal transplantation","volume":"136","author":"Van de Berg","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.kint.2018.01.021_bib22","first-page":"175","article-title":"Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report","volume":"178","author":"Zhao","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.01.021_bib23","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1600-6143.2011.03963.x","article-title":"Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus","volume":"12","author":"Singh","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1440-1797.2012.01578.x","article-title":"Foxp3(+) T cells in peripheral blood of renal transplant recipients and clinical correlations","volume":"17","author":"Lin","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.kint.2018.01.021_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1399-0012.2006.00584.x","article-title":"Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients","volume":"21","author":"Baan","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1681\/ASN.2008050450","article-title":"Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients","volume":"20","author":"Ashton-Chess","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.01.021_bib27","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1111\/j.1600-6143.2006.01566.x","article-title":"CD4+CD25 bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients","volume":"6","author":"Velthuis","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1600-6143.2005.00758.x","article-title":"Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in\u00a0vitro","volume":"5","author":"Game","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib29","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.transproceed.2006.08.081","article-title":"Calcineurin inhibitors affect circulating regulatory T cells in stable renal transplant recipients","volume":"38","author":"San Segundo","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.kint.2018.01.021_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1399-0012.2009.01086.x","article-title":"Two-year follow-up of a prospective study of circulating regulatory T cells in renal transplant patients","volume":"24","author":"San Segundo","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1681\/ASN.2006101143","article-title":"Regulatory T cells and T cell depletion: role of immunosuppressive drugs","volume":"18","author":"Noris","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.01.021_bib32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/360264a0","article-title":"Lifespan of human lymphocyte subsets defined by CD45 isoforms","volume":"360","author":"Michie","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.kint.2018.01.021_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.272.5258.60","article-title":"Lymphocyte homing and homeostasis","volume":"272","author":"Butcher","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.kint.2018.01.021_bib34","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.kint.2018.01.021_bib35","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2004-05-2044","article-title":"Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD","volume":"105","author":"Ermann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.01.021_bib36","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.01.021_bib37","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.01.021_bib38","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2215\/CJN.09611010","article-title":"Monitoring of CD4+CD25highIL-7R\u03b1high activated T cells in kidney transplant recipients","volume":"6","author":"Vallotton","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.01.021_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib40","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.4049\/jimmunol.163.6.3194","article-title":"CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses","volume":"163","author":"Whitmire","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib41","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1128\/jvi.70.12.8375-8381.1996","article-title":"CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection","volume":"70","author":"Whitmire","year":"1996","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.kint.2018.01.021_bib42","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.intimp.2011.03.021","article-title":"Stimulation-dependent induction of CD154 on a subset of CD4+ FoxP3+ T-regulatory cells","volume":"11","author":"Li","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.kint.2018.01.021_bib43","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/ajt.12629","article-title":"Novel GMP-compatible protocol employing an allogeneic B cell bank for clonal expansion of allospecific natural regulatory T cells","volume":"14","author":"Landwehr-Kenzel","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib44","unstructured":"Regulation (EC) No 1394\/2007 of the European Parliament and of the Council of 13 November 2007 on Advanced Therapy Medicinal Products and Amending Directive 2001\/83\/EC and Regulation (EC) No 726\/2004. Off J Eur Union. Available at: http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-1\/reg_2007_1394\/reg_2007_1394_en.pdf. Accessed January 1, 2018."},{"key":"10.1016\/j.kint.2018.01.021_bib45","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1600-6143.2006.01280.x","article-title":"Clinical operational tolerance after kidney transplantation","volume":"6","author":"Roussey-Kesler","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib46","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1432-2277.2011.01260.x","article-title":"Spontaneous tolerance in kidney transplantation\u2013an instructive, but very rare paradigm","volume":"24","author":"Cipp\u00e0","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.kint.2018.01.021_bib47","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/SLA.0b013e3181f3efb0","article-title":"Clinical operational tolerance after renal transplantation: current status and future challenges","volume":"252","author":"Orlando","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.kint.2018.01.021_bib48","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.humimm.2010.01.022","article-title":"Differential monocyte STAT6 activation and CD4(+)CD25(+)Foxp3(+) T cells in kidney operational tolerance transplanted individuals","volume":"71","author":"Moraes-Vieira","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3389\/fimmu.2013.00497","article-title":"Regulatory B cells and tolerance in transplantation: from animal models to human","volume":"4","author":"Chesneau","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib50","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1432-2277.2007.00537.x","article-title":"Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome","volume":"20","author":"Braudeau","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.kint.2018.01.021_bib51","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1172\/JCI39922","article-title":"Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans","volume":"120","author":"Sagoo","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2018.01.021_bib52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.tp.0000203166.44968.86","article-title":"Contrasting CD25hiCD4+T cells\/FOXP3 patterns in chronic rejection and operational drug-free tolerance","volume":"81","author":"Louis","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.01.021_bib53","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2014050480","article-title":"Central role of CD45RA- Foxp3hi memory regulatory T cells in clinical kidney transplantation tolerance","volume":"26","author":"Braza","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.01.021_bib54","doi-asserted-by":"crossref","first-page":"e34208","DOI":"10.1371\/journal.pone.0034208","article-title":"DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients","volume":"7","author":"Schaier","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.01.021_bib55","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1093\/ndt\/gfp435","article-title":"FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis","volume":"24","author":"Zuber","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib56","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.coi.2011.06.006","article-title":"Regulatory T cells in stem cell transplantation: strategies and first clinical experiences","volume":"23","author":"Edinger","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib57","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex\u00a0vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.01.021_bib58","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.01.021_bib59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex\u00a0vivo expanded CD4+CD25+CD127- T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib60","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/j.1600-6143.2012.04143.x","article-title":"Permanent CNI treatment for prevention of renal allograft rejection in sensitized hosts can be replaced by regulatory T cells","volume":"12","author":"Siepert","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib61","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/TP.0b013e3181ff8772","article-title":"Ex\u00a0vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model","volume":"90","author":"Issa","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.01.021_bib62","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.coi.2011.06.005","article-title":"Regulatory T cells as modulators of chronic allograft dysfunction","volume":"23","author":"Issa","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib63","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.humimm.2015.11.006","article-title":"Immunosuppressive drugs affect induction of IFNy\u00a0+ Treg in\u00a0vitro","volume":"77","author":"Daniel","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2016.01.004","article-title":"Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients","volume":"35","author":"Latorre","year":"2016","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/nep.12894","article-title":"Evaluation of CD4+ CD25+\/- CD39+ T-cell populations in peripheral blood of patients following kidney transplantation and during acute allograft rejection","volume":"22","author":"McRae","year":"2017","journal-title":"Nephrology"},{"key":"10.1016\/j.kint.2018.01.021_bib66","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/TP.0b013e318199fa57","article-title":"Expression of regulatory T-cell-related molecule genes and clinical outcome in kidney transplant recipients","volume":"87","author":"Alvarez","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.01.021_bib67","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.kint.2016.09.043","article-title":"Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs","volume":"91","author":"Litjens","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.01.021_bib68","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/sji.12287","article-title":"Immunological profiling of haemodialysis patients and young healthy individuals with implications for clinical regulatory T cell sorting","volume":"81","author":"Bergstr\u00f6m","year":"2015","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib69","doi-asserted-by":"crossref","first-page":"e92888","DOI":"10.1371\/journal.pone.0092888","article-title":"Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation","volume":"9","author":"Satake","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.01.021_bib70","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4049\/jimmunol.0900936","article-title":"Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients","volume":"184","author":"Raimondi","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib71","doi-asserted-by":"crossref","first-page":"e10352","DOI":"10.1371\/journal.pone.0010352","article-title":"Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation","volume":"5","author":"Muller","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.01.021_bib72","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood-2006-01-0329","article-title":"Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production","volume":"108","author":"Zeiser","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.01.021_bib73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3324\/haematol.2015.128934","article-title":"Impact of immunosuppressive drugs on the therapeutic efficacy of ex\u00a0vivo expanded human regulatory T cells","volume":"101","author":"Scott\u00e0","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.kint.2018.01.021_bib74","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.transproceed.2007.09.015","article-title":"The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation","volume":"39","author":"Korczak-Kowalska","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.kint.2018.01.021_bib75","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/intimm\/dxp005","article-title":"Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance","volume":"21","author":"Nagahama","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib76","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2010.03210.x","article-title":"Immune reconstitution following rabbit antithymocyte globulin","volume":"10","author":"Gurkan","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib77","doi-asserted-by":"crossref","first-page":"e104408","DOI":"10.1371\/journal.pone.0104408","article-title":"Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study","volume":"9","author":"Grafals","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.01.021_bib78","first-page":"651","article-title":"Antigen-specific regulatory T cells and low dose of IL-2 in t of type 1 diabetes","volume":"6","author":"Pham","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib79","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2018.01.021_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005265","article-title":"Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease","volume":"5","author":"Matsuoka","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.kint.2018.01.021_bib81","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","article-title":"Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata","volume":"150","author":"Castela","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.kint.2018.01.021_bib82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2015.01.001","article-title":"Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients","volume":"58","author":"Rosenzwajg","year":"2015","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.kint.2018.01.021_bib83","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1078-0432.CCR-13-3205","article-title":"Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity","volume":"20","author":"Kennedy-Nasser","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.kint.2018.01.021_bib84","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/mt.2014.50","article-title":"Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in hHealthy volunteers","volume":"22","author":"Ito","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.kint.2018.01.021_bib85","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","article-title":"Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease","volume":"128","author":"Koreth","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.01.021_bib86","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.tp.0000229473.95202.50","article-title":"Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FoxP3+ regulatory T cells in renal transplant recipients","volume":"82","author":"Segundo","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.01.021_bib87","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ki.2014.350","article-title":"Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus","volume":"87","author":"Gallon","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.01.021_bib88","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/TP.0b013e31819d2032","article-title":"Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells","volume":"87","author":"Demirkiran","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.01.021_bib89","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1600-6143.2008.02260.x","article-title":"Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: clinical outcomes and effect on T-regulatory cells","volume":"8","author":"Pascual","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib90","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1600-6143.2007.01842.x","article-title":"Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells","volume":"7","author":"Gao","year":"2007","journal-title":"Am J Transpl"},{"key":"10.1016\/j.kint.2018.01.021_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000313940","article-title":"Different immunosuppressive combinations on T-cell regulation in renal transplant recipients","volume":"32","author":"Fourtounas","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2018.01.021_bib92","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/TP.0b013e3182590d8f","article-title":"In\u00a0vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function","volume":"94","author":"Miroux","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.01.021_bib93","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/01.TP.0000153505.73700.32","article-title":"Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in\u00a0vivo","volume":"79","author":"Kawai","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.01.021_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/614297","article-title":"Regulatory T cells resist cyclosporine-induced cell death via CD44-mediated signaling pathways","volume":"2015","author":"Ruppert","year":"2015","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.kint.2018.01.021_bib95","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ki.2009.198","article-title":"Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor\u2013based drug regimens","volume":"76","author":"Presser","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.01.021_bib96","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.trim.2012.09.003","article-title":"Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR\u00a0+ \u2013Treg-cells in transplanted patients","volume":"27","author":"Seissler","year":"2012","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib97","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0404.2008.01090.x","article-title":"Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis","volume":"119","author":"Braitch","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.kint.2018.01.021_bib98","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jaci.2004.07.014","article-title":"Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma","volume":"114","author":"Karagiannidis","year":"2004","journal-title":"J.\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib99","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1002\/eji.200635873","article-title":"Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cellsin\u00a0vivo and enhances their capacity to suppress EAE","volume":"36","author":"Chen","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2249.2009.03987.x","article-title":"Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis","volume":"158","author":"Xu","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib101","doi-asserted-by":"crossref","first-page":"e24345","DOI":"10.1371\/journal.pone.0024345","article-title":"Influence of short-term glucocorticoid therapy on regulatory T cells in vivo","volume":"6","author":"Sbiera","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.01.021_bib102","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","article-title":"Ex\u00a0vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood","volume":"193","author":"Dieckmann","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.01.021_bib103","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood.V98.9.2736","article-title":"Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells","volume":"98","author":"Ng","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.01.021_bib104","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.193.11.1295","article-title":"Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in\u00a0vitro without loss of function","volume":"193","author":"Levings","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.01.021_bib105","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.193.11.1285","article-title":"Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood","volume":"193","author":"Jonuleit","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.01.021_bib106","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib107","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1093\/jimmunol\/186.7.3808","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"186","author":"Sakaguchi","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib108","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4\u00a0+ CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib109","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2018.01.021_bib110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.kint.2018.01.021_bib111","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib112","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib113","doi-asserted-by":"crossref","first-page":"e3161","DOI":"10.1371\/journal.pone.0003161","article-title":"Clinical grade Treg: GMP isolation, improvement of purity by CD127 depletion, Treg expansion, and Treg cryopreservation","volume":"3","author":"Peters","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.01.021_bib114","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.exphem.2011.08.010","article-title":"Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability and expansion capacity","volume":"39","author":"Ukena","year":"2011","journal-title":"Exp. Hematol"},{"key":"10.1016\/j.kint.2018.01.021_bib115","doi-asserted-by":"crossref","first-page":"e3161","DOI":"10.1371\/journal.pone.0003161","article-title":"Clinical grade Treg: GMP isolation, improvement of purity by CD127 depletion, Treg expansion, and Treg cryopreservation","volume":"3","author":"Peters","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.01.021_bib116","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12026-012-8267-9","article-title":"Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD","volume":"53","author":"Haase","year":"2012","journal-title":"Immunol Res"},{"key":"10.1016\/j.kint.2018.01.021_bib117","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib118","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/ndt\/gfr693","article-title":"Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy","volume":"27","author":"Krystufkova","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.01.021_bib119","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2215\/CJN.12931212","article-title":"Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation","volume":"8","author":"Afzali","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.01.021_bib120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.trim.2011.09.003","article-title":"Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation","volume":"26","author":"Berglund","year":"2012","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib121","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cei.12112","article-title":"Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials","volume":"173","author":"Berglund","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib122","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1797.2009.01172.x","article-title":"Regulatory T cells\/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events","volume":"15","author":"Zhang","year":"2010","journal-title":"Nephrology"},{"key":"10.1016\/j.kint.2018.01.021_bib123","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/eji.201040531","article-title":"Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells","volume":"40","author":"Simonetta","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2018.01.021_bib124","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature10664","article-title":"Response to self antigen imprints regulatory memory in tissues","volume":"480","author":"Rosenblum","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.kint.2018.01.021_bib125","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cyto.a.20640","article-title":"The influence of different stimulation conditions on the assessment of antigen-induced CD154 expression on CD4+ T cells","volume":"73","author":"Meier","year":"2008","journal-title":"Cytometry A"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818301340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818301340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:51:41Z","timestamp":1758761501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818301340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":125,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0085253818301340"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.01.021","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex\u00a0vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}